Sunshine Biopharma (SBFM) Filings

EFFECT

SBFM Sunshine Biopharma Inc

6 Jun 23

Notice of effectiveness

12:15am

424B3

SBFM Sunshine Biopharma Inc

5 Jun 23

Prospectus supplement

5:28pm

D

SBFM Sunshine Biopharma Inc

17 May 23

$5.00 mm in equity / options, sold $5.00 mm, 1 investor

1:30pm

8-K

SBFM Sunshine Biopharma Inc

16 May 23

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

4:05pm

8-K

SBFM Sunshine Biopharma Inc

11 May 23

Results of Operations and Financial Condition

4:59pm

PRE 14A

SBFM Sunshine Biopharma Inc

2 May 23

Preliminary proxy

1:57pm

8-K

SBFM Sunshine Biopharma Inc

19 Apr 23

Amendments to Articles of Incorporation or Bylaws

8:00am

NT 10-K

SBFM Sunshine Biopharma Inc

31 Mar 23

Notice of late annual filing

2:26pm

8-K

SBFM Sunshine Biopharma Inc

24 Mar 23

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:45pm

8-K

SBFM Sunshine Biopharma Inc

28 Feb 23

SUNSHINE BIOPHARMA SIGNS EXCLUSIVE WORLDWIDE LICENSE WITH UNIVERSITY OF ARIZONA FOR PLpro-BASED COVID-19 TREATMENT

7:16am

8-K

SBFM Sunshine Biopharma Inc

13 Feb 23

Other Events

2:57pm

8-K

SBFM Sunshine Biopharma Inc

10 Feb 23

SUNSHINE BIOPHARMA SIGNS RESEARCH AGREEMENT WITH THE JEWISH GENERAL HOSPITAL TO ADVANCE THE DEVELOPMENT OF Adva-27a ANTICANCER COMPOUND

7:30am

8-K/A

SBFM Sunshine Biopharma Inc

12 Dec 22

Financial Statements and Exhibits

4:31pm

8-K

SBFM Sunshine Biopharma Inc

9 Dec 22

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:05pm

4

Sebaaly Camille

2 Dec 22

Sunshine Biopharma / Camille Sebaaly ownership change

6:01am

SC 13G

Malek Chamoun

2 Nov 22

Sunshine Biopharma / Chamoun Malek ownership change

11:13am